drug candidate

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

South Korea's Daewon Pharmaceutical Co. will export its nonsteroidal anti-inflammatory drug (NSAID) Pelubi to the Indonesian market. It's South Kore...

SK Chemicals Co., a South Korean plastic materials producer, is in exclusive talks with Seoul-based Glenwood Private Equity to sell its pharmaceutic...

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...

South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...

KB Financial Group Inc. has chosen Yang Jong-hee, its vice chairman, as the sole candidate for its next chief in charge of South Korea’s leadi...

South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...

South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...

South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...

South Korean bio-health company HK inno.N announced on Monday that it has released the new drug K-CAB for gastroesophageal reflux disease (GERD) in ...

A drug candidate in South Korea could allow people seeking to lose weight to eat to their heart's content.The Center for Cognition and Sociality of ...

South Korea’s biotechnology startup Voronoi Inc. announced on Monday that it is intensifying its artificial intelligence (AI)-driven new drug ...

South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...

South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

South Korea's SK Biopharmaceuticals announced on Friday a strategic tie-up with Hikma MENA FZE, marking the introduction of its new epilepsy medicat...

Japanese insurer Tokio Marine Holdings Inc. is seeking to sell its units in Southeast Asia for $1 billion to major South Korean companies looking fo...

South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

South Korea's SK Biopharmaceuticals assembled its Scientific Advisory Board (SAB) composed of world-renowned physicians and drug development experts...

South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...

South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...